Your Current Position: NEWS
-
We keep receiving positive feedback from our customers. We are a company that conducts business with integrity. -
Recent investments in GMP-compliant facilities and quality management systems have enabled Chinese manufacturers to meet stringent international regulatory requirements, including US FDA and EMA standards. The trend is expected to accelerate as multinational pharmaceutical companies seek reliable, high-quality supply chain partners. -
GLP-1 receptor agonists, such as Semaglutide and Tirzepatide, have emerged as key drivers of this expansion, revolutionizing weight management and diabetes care. The growing acceptance of peptide-based therapies among healthcare professionals and patients alike is fueling investment in research, manufacturing capacity, and global supply chains. -
2024-07-18Visitors from Europe, Southeast Asia, and the Middle East engaged with the Chengque team to discuss product specifications, customization options, and supply chain capabilities. The company highlighted its commitment to GMP-aligned manufacturing and rigorous purity testing. -
2022-03-02With a commitment to quality assurance and third-party testing, Chengque Technology aims to become a trusted partner in the rapidly growing peptide market. The company offers flexible OEM services, secure logistics, and multilingual customer support.
Mob: +86 147 3718 6312, from 9 am to 5:30 pm, Monday to Friday. Mobile / WhatsApp / Telegram: +86 147 3718 6312
Email:Asa@sfchengque.com / Seren@sfchengque.com / Elara@sfchengque.com
Copyright(C) 2018-2026 All Right Reserved. Zhengzhou Chengque Technology Co., Ltd.Design by sfchengque.com